Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma
Clinical trial NCT00917384 · COMPLETED
Trial details
- NCT number
- NCT00917384
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2012-07-01
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.